6CM
FOLD

683 Capital Management’s Amicus Therapeutics FOLD Stock Holding History

683 Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-295,500
Closed -$4.19M – 173
2023
Q4 		$4.19M Buy
+295,500
New +$3.36M 0.34% 65

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

683 Capital Management's FOLD Position: Q2 2026 in Review

683 Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 775,000 shares — an estimated $11.2M sold.

683 Capital Management first reported a position in FOLD in Q1 2025 and held it in 5 quarters. The position peaked at $11.4M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • 683 Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • 683 Capital Management sold 775,000 Amicus Therapeutics shares in Q2 2026, an estimated $11.2M.
  • 683 Capital Management first reported a position in Amicus Therapeutics in Q1 2025 and held it in 5 quarters.
  • 683 Capital Management's Amicus Therapeutics position peaked at $11.4M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.